Sophie Living Visonneau from 3794 Mykonos Ln #38, San Diego, CA 92130, age 62, Phone: (858)7947692

Us Patents

Thrombopoietin Mimetics
view source
US Patent:

7473686, Jan 6, 2009
Filed:

Jan 8, 2007
Appl. No.:

11/650651
Inventors:

Kevin J. Duffy - Collegeville PA, US
Julian Jenkins - Collegeville PA, US
Juan I. Luengo - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
Assignee:

SmithKline Beecham Corp. - Philadelphia PA
International Classification:

C07D 231/46
A61K 31/4152
A61K 31/655
US Classification:

514150, 514404, 534792, 5483674
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Thrombopoietin Mimetics
view source
US Patent:

7648971, Jan 19, 2010
Filed:

Jun 18, 2008
Appl. No.:

12/141422
Inventors:

Kevin J. Duffy - Collegeville PA, US
Julian Jenkins - Collegeville PA, US
Juan I. Luengo - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
Assignee:

SmithKline Beecham Corp. - Philadelphia PA
International Classification:

A61K 31/655
A61K 31/4152
C07C 245/10
C07D 231/46
US Classification:

514150
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Thrombopoietin Mimetics
view source
US Patent:

20070129338, Jun 7, 2007
Filed:

Jan 5, 2007
Appl. No.:

11/620260
Inventors:

Kevin DUFFY - Collegeville PA, US
Daniel Eppley - Abilene TX, US
Julian Jenkins - Collegeville PA, US
Juan Luengo - Collegevile PA, US
Nannan Liu - Collegeville PA, US
Alan Price - Collegeville PA, US
Antony Shaw - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
Kenneth Wiggall - Collegeville PA, US
International Classification:

A61K 31/655
US Classification:

514150000, 534769000
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Thrombopoietin Mimetics
view source
US Patent:

20070179192, Aug 2, 2007
Filed:

Nov 9, 2006
Appl. No.:

11/558071
Inventors:

Kevin Duffy - Collegeville PA, US
Julian Jenkins - Collegevile PA, US
Juan Luengo - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
International Classification:

A61K 31/416
A61K 38/18
A61K 38/19
A61K 38/20
C07D 403/02
US Classification:

514381000, 548253000, 424085100, 424085200, 514012000
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Thrombopoietin Mimetics
view source
US Patent:

20080090787, Apr 17, 2008
Filed:

Jan 8, 2007
Appl. No.:

11/650838
Inventors:

Kevin Duffy - Collegeville PA, US
Daniel Eppley - Abilene TX, US
Julian Jenkins - Collegeville PA, US
Juan Luengo - Collegeville PA, US
Nannan Liu - Cllegeville PA, US
Alan Price - Collegeville PA, US
Antony Shaw - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
Kenneth Wiggall - Collegeville PA, US
International Classification:

A61K 31/655
A61P 7/00
C09B 29/00
US Classification:

514150000, 534753000
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Thrombopoietin Mimetics
view source
US Patent:

20080090996, Apr 17, 2008
Filed:

Jan 8, 2007
Appl. No.:

11/650688
Inventors:

Kevin Duffy - Collegeville PA, US
Daniel Eppley - Abilene TX, US
Julian Jenkins - Collegeville PA, US
Juan Luengo - Collegeville PA, US
Nannan Liu - Collegeville PA, US
Alan Price - Collegeville PA, US
Antony Shaw - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
Kenneth Wiggall - Collegeville PA, US
International Classification:

C09B 29/00
US Classification:

534579000
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Thrombopoietin Mimetics
view source
US Patent:

20090155203, Jun 18, 2009
Filed:

Jun 18, 2008
Appl. No.:

12/141397
Inventors:

Kevin J. Duffy - Collegeville PA, US
Daniel F. Eppley - Abilene TX, US
Julian Jenkins - Collegeville PA, US
Juan I. Luengo - Collegeville PA, US
Nannan Liu - Collegeville PA, US
Alan T. Price - Collegeville PA, US
Antony N. Shaw - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
International Classification:

A61K 31/655
A61K 38/17
A61K 38/19
A61K 38/20
US Classification:

424 852, 514150, 424 851
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Thrombopoietin Mimetics
view source
US Patent:

20090176973, Jul 9, 2009
Filed:

Jun 18, 2008
Appl. No.:

12/141379
Inventors:

Kevin J. Duffy - Collegeville PA, US
Daniel F. Eppley - Abilene TX, US
Julian Jenkins - Collegeville PA, US
Juan I. Luengo - Collegeville PA, US
Nannan Liu - Collegeville PA, US
Alan T. Price - Collegeville PA, US
Antony N. Shaw - Collegeville PA, US
Sophie Visonneau - Collegeville PA, US
Kenneth Wiggall - Collegeville PA, US
International Classification:

C09B 27/00
C07C 59/42
C07D 231/38
US Classification:

534751, 562469, 5483717
Abstract:

Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Name / Title

Company / Classification

Phones & Addresses

Sophie Visonneau
Senior Director Clinical Operations

BIOGEN IDEC INC
Biopharmaceutical Products · Pharmaceutical Preparations · Pharmaceutical Preparations Biological Products & Research · Other Biological Prod Mfg

14 Cambridge Ctr, Cambridge, MA 02142
425 W Capitol Ave STE 1700, Little Rock, AR 72201
1209 Orange St, Wilmington, DE 19801
10 Cambridge Ctr, Cambridge, MA 02142
(617)6213303, (617)6792000, (617)6793170, (617)6792617

Resumes

Vice President Clinical Operations

view source

Location:

San Diego, CA

Industry:

Biotechnology

Work:

Tocagen Inc.
Vice President Clinical Operations
Tioga Pharmaceuticals Apr 2014 - Feb 2018
Chief Operating Officer
Shire Jan 2012 - Mar 2014
Senior Director, Head Global Clinical Operations
Polynoma Jul 2011 - Jan 2012
Vice-President, Clinical Operations
Biogen Feb 2010 - Mar 2011
Senior Director, Global Clinical Operations International

Education:

University of Sciences Pierre Et Marie Curie, Paris 1992
Doctorates, Doctor of Philosophy University of Sciences Pierre Et Marie Curie, Paris 1987
Master of Science, Masters, Immunology University of Medical Sciences Kremlin - Bicetre, Paris 1986
University of Sciences Pierre Et Marie Curie, Paris 1986
Bachelors, Bachelor of Science, Biochemistry

Skills:

Clinical Development
Clinical Trials
Oncology
Cro
Biotechnology
Pharmaceutical Industry
Gcp
Regulatory Submissions
Ind
Fda
Biopharmaceuticals
Ctms
Drug Development
Clinical Research
Drug Discovery
Regulatory Affairs
Therapeutic Areas
Immunology
Medical Affairs
Protocol
Cancer
Glp
Pharmacology
Sop
Cross Functional Team Leadership
Clinical Study Design
Lifesciences
Hematology
Assay Development
Neurology
Clinical Monitoring
Ich Gcp
Regulatory Filings
Global Operations
Global Management
Regenerative Medicine
Operational Due Diligence
Organizational Effectiveness
Organizational Design
Business Transition Planning
Integration
Business Development
Consulting
Global Strategy
Divestitures
Knowledge Transfer
Driving Operational Excellence
Performance Metrics
Key Performance Indicators
Rheumatoid Arthritis

Languages:

English
French

Director, Global Clinical Operations At Biogen Idec

view source

Sophie Visonneau San Diego, CA

view source

Work:

Global Clinical Operations International

Feb 2010 to 2000
Senior Director Global Clinical Operations Oncology Therapeutic Area

Jul 2008 to Feb 2010
Senior Director Clinical Operations Oncology Therapeutic Area

Feb 2007 to Jul 2008
Director AMGEN

Apr 2006 to Feb 2007
Director AMGEN

Jul 2004 to Feb 2007
e-CTD Module 5 and Module 2 Leader AMGEN

Apr 2004 to Jul 2004
Associate Director, Global Clinical Research Management, Oncology Therapeutic Area Development AMGEN

Apr 2002 to Apr 2004
Senior Manager, Clinical Research Management, Oncology Therapeutic Area Development IMMUNOMEDICS Inc
Morris Plains, NJ
Sep 2001 to Apr 2002
Director, Oncology Therapeutic Product Development GLAXOSMITHKINE, SMITHKLINE BEECHAM

Jun 2001 to Sep 2001
Senior Scientist, Biologics Group GLAXOSMITHKINE, SMITHKLINE BEECHAM
Collegeville, PA
Sep 1999 to Sep 2001 GLAXOSMITHKINE, SMITHKLINE BEECHAM

Nov 2000 to Jun 2001
Senior Clinical Scientist, Oncology GLAXOSMITHKINE, SMITHKLINE BEECHAM

Sep 1999 to Nov 2000
Clinical Scientist, Oncology, Clinical Research, Development & Medical Affairs THE WISTAR INSTITUTE

Jun 1995 to Sep 1999
Staff Scientist THE WISTAR INSTITUTE
Philadelphia, PA
Jun 1992 to Sep 1999 THE WISTAR INSTITUTE

1997 to 1999
Member THE WISTAR INSTITUTE

Jun 1992 to Jun 1995
Post-doctoral Fellow THOMAS JEFFERSON UNIVERSITY, Bluemle Life Sciences Building
Philadelphia, PA
Jun 1991 to Jun 1992
Research Assistant (in the laboratory of Pr. B Perussia) HOSPITAL LA PITIE-SALPETRIERE
Paris (75)
Jun 1986 to Jun 1991
Pre-doctoral Fellow (in the laboratory of Pr. D Khayat) HOSPITAL LA PITIE-SALPETRIERE

Jul 1986 to Sep 1986
Summer Internship (in the laboratory of Dr. M Castagna)

Education:

University of Medical Sciences Kremlin
San Diego, CA
Feb 2007 to 2000
Oncology and Tumor Immunology University of Sciences Pierre et Marie Curie
Paris (75)
1992
PhD University of Saint
1990
Immunology Course, The American Association of Immunology University of Sciences Pierre et Marie Curie
Paris (75)
1987
MS in Immunology University of Sciences Pierre et Marie Curie
Paris (75)
1986
B.Sc. in Biochemistry